Sign in to view content

Treatment Response to Antioxidant Supplementation Based on CFH and ARMS2Â Genetic Risk Allele Number in AREDS Patients With No AMD at Baseline

Carl C. Awh, MD, FASRS

Video
Published 2016

Related

The Updated AREDS Simplified Severity Scale for Age-Related Macular Degeneration, Incorporating Reticular Pseudodrusen
Tiarnan D Keenan, BM BCh, PhD
Updates from the Field
2024
Retina PractiCare: Coding Benchmarks for Retina Specialists
John T. Thompson, MD
Annual Meeting Talks
2016
HIPPA and Malpractice Pitfalls in Providing Care to Infants at Risk for Retinopathy of Prematurity (ROP) For Physicians Employing Digital Imaging Technologies
Antonio Capone, MD
Annual Meeting Talks
2016

Category: AMD-Non-Neovascular

See more